Could MODY Cause Low Blood Sugar in My Baby at Birth?

If you have HNF4A-MODY (and in rarer cases, HNF1A-MODY), your baby may have a higher risk of low blood sugar (neonatal hypoglycemia) at birth ^[1]. This risk comes from two different pathways: the ordinary fetal response to maternal blood sugar levels during pregnancy, and the risk of the baby directly inheriting the MODY genetic variant from you ^[2][3].

Because HNF4A and HNF1A variants follow an autosomal dominant inheritance pattern, there is a 50% chance your baby will inherit the variant ^[4][5]. While the possibility of your newborn having low blood sugar can be stressful, advance planning with your obstetric and pediatric teams substantially reduces the risk of severe outcomes.

Why Does HNF4A-MODY Increase This Risk?

In fetuses and newborns, inheriting an HNF4A variant (and less commonly, an HNF1A variant) can cause the pancreas to secrete inappropriate, excessive amounts of insulin—a condition called congenital hyperinsulinism ^[6][4]. This affects the baby in two main ways:

• Large Birth Weight (Macrosomia): Insulin acts like a growth hormone in the womb. The extra insulin can make the baby grow much larger than average. Babies with HNF4A-related hyperinsulinism are often born weighing over 8 pounds, 13 ounces (4,000 grams) ^[1][3]. However, it is important to know that a baby can still be born at an average weight and have this risk, so size alone does not rule out hyperinsulinism ^[7].
• The Post-Natal Blood Sugar Crash: In the womb, the baby gets a constant supply of glucose (sugar) from you. After birth, that supply stops, but a baby with hyperinsulinism continues to produce too much insulin. This excess insulin rapidly clears sugar from the baby’s blood. Crucially, high insulin also suppresses the breakdown of fat and the production of ketones (which serve as alternative fuels for the brain) ^[6][8]. This leaves the baby without backup energy, leading to a sudden drop in blood sugar.

What about HNF1A? Neonatal hyperinsulinism is a well-established feature of HNF4A-MODY. Reports of it occurring in HNF1A-MODY pregnancies exist, but they are much more limited and may depend on the specific genetic variant and family history ^[4][5].

Symptoms to Watch For

Because your medical team knows your diagnosis, they will monitor your baby’s blood sugar to catch drops before symptoms appear. However, alert a nurse or doctor immediately if you notice:

• Jitteriness, tremors, or shaking
• Poor feeding or weak sucking
• Extreme sleepiness, lethargy, or limpness
• Pale or bluish skin, or temperature instability
• Pauses in breathing (apnea) or seizures

What to Expect at the Hospital

You should discuss a newborn glucose screening plan with your pediatric or neonatal team before delivery. Standard hospital protocols for at-risk infants generally involve:

• Early Feeding: You will likely be encouraged to feed your baby very soon after birth to provide an immediate source of energy. Breast milk, expressed colostrum, donor milk, and formula are all appropriate options ^[9].
• Screening Checks: Nurses will use a bedside meter to check your baby’s blood sugar via a heel prick. These checks often start within a couple of hours of birth and continue regularly ^[9]. Bedside meters are screening tools; very low or persistent readings are usually confirmed with a laboratory-quality blood draw, though treatment will not be delayed for a symptomatic infant ^[10][11].
• Dextrose Gel: If the baby’s blood sugar dips but they are asymptomatic, a common early treatment is massaging sweet dextrose gel into the inside of their cheek (buccal mucosa), usually alongside a feed ^[12]. While gel is helpful, it is not a universal substitute for intravenous (IV) treatment if the hypoglycemia is severe, persistent, or symptomatic.
• IV Dextrose: If the baby’s blood sugar remains dangerously low or if they have symptoms, they will need a continuous drip of glucose directly into a vein (IV dextrose) ^[13]. Depending on the hospital’s capabilities, this may be done in the newborn nursery so you can stay together, or it may require a transfer to the Neonatal Intensive Care Unit (NICU).

When Hypoglycemia Persists

For many babies of diabetic mothers, low blood sugar is a temporary transition phase lasting a couple of days ^[14]. But if it persists beyond the usual transitional period or requires high amounts of IV dextrose, the team will evaluate the baby for congenital hyperinsulinism.

• The “Critical Sample”: To confirm hyperinsulinism, the medical team will draw a blood sample while the baby’s blood sugar is low. They will test for insulin, C-peptide, ketones, and free fatty acids to see if insulin levels are inappropriately high when they should be suppressed ^[11][15].
• Specialist Medications: For a small number of babies with confirmed, persistent hyperinsulinism, a pediatric endocrinologist may prescribe specialized medications like diazoxide to suppress insulin production ^[7][16]. This is not a routine newborn treatment and requires careful specialist monitoring due to potential side effects like fluid retention.

Because HNF4A-MODY has lifelong implications, confirm your own specific genetic variant and share your genetic report with your obstetric and pediatric teams so they can provide the most targeted, individualized care for you and your baby.